Drug Shortage Report for JAMP NEVIRAPINE
| Report ID | 162493 |
| Drug Identification Number | 02405776 |
| Brand name | JAMP NEVIRAPINE |
| Common or Proper name | Nevirapine Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | NEVIRAPINE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | J05AG |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-31 |
| Estimated end date | 2022-11-30 |
| Actual end date | 2022-09-02 |
| Shortage status | Resolved |
| Updated date | 2022-09-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-09-06 | French | Compare |
| v7 | 2022-09-06 | English | Compare |
| v6 | 2022-08-30 | French | Compare |
| v5 | 2022-08-30 | English | Compare |
| v4 | 2022-08-02 | French | Compare |
| v3 | 2022-08-02 | English | Compare |
| v2 | 2022-06-13 | French | Compare |
| v1 | 2022-06-13 | English | Compare |
Showing 1 to 8 of 8